Intestinal Development in Wuzhishan Pigs at Different Growth Phases: Insights from Microbiome and Metabolomics
Animals · 20.03.2026 · 16 (6) · 976
DOI: 10.3390/ani16060976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 20.03.2026. Verfasst von Jing Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Animal Breeding and Epidemic Disease Research, Institute of Animal Husbandry and Veterinary Research, Hainan Academy of Ag…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key R&D Program of China, National Natural Science Foundation of China, The 2020 Research Program of Sanya Yazhou Bay Science and Technology City.
Abstract (Originalsprache)
Wuzhishan pigs are a typical Chinese indigenous miniature pig breed, with thin skin and high amino acid content in muscle; slow weight gain and long feeding phases limit their value. As the primary digestive and absorptive organ, the intestine is crucial for growth, yet current studies on its development are limited. This study aimed to investigate intestinal physiological differences in Wuzhishan pigs across four phases (pre-weaning: 7, 14 days; weaning: 35, 38, 45 days; fattening: 70, 100 days; maturity: 180, 240 days) by evaluating intestinal morphology, digestive enzyme activity, gut microbiota diversity via 16S rRNA gene sequencing, and metabolite characteristics via metabolomic analysis. Results showed poor intestinal morphology and enzyme activity during weaning, significant ileal and colonic microbial diversity differences across phases, increased beneficial bacteria with age, and enriched opportunistic pathogens (Streptococcus, Romboutsia, Terrisporobacter) during weaning; weaning also had lower lipid metabolites, correlated with decreased Fusobacterium, Lactobacillus, and Muribaculaceae. Fattening enhanced amino acid metabolism, with increased Lactobacillus correlated with higher amino acids and muscle-related metabolites, while maturity increased immune-related metabolites (e.g., pyridoxine) in the vitamin B6 pathway. These results explain delayed rapid weight gain in Wuzhishan pigs and provide a theoretical basis for maintaining intestinal stability and production performance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Tropical Animal Breeding and Epidemic Disease Research, Institute of Animal Husbandry and Veterinary Research, Hainan Academy of Agricultural Sciences, Haikou 571100, China.
- National Engineering Research Center for Breeding Swine Industry, Chinese National Centre of Pig Breeding Technology, ALLTECH-SCAU Animal Nutrition Control Research Alliance, College of Animal Science, South China Agric…
- College of Animal Science and Technology, Guangxi University, Nanning 530005, China.
ORCID-Profile: Jing Fan
Förderung
- The National Key R&D Program of China
- National Natural Science Foundation of China
- The 2020 Research Program of Sanya Yazhou Bay Science and Technology City
- Hainan Local Pig Agricultural Research System
- The National Key R&D Program of China
Zitieren
APA
Fan, J., Xue, X., Zhang, H., Wang, F., Chao, Z., Wei, L., Liu, H., Ren, Y., & Sun, R. (2026). Intestinal Development in Wuzhishan Pigs at Different Growth Phases: Insights from Microbiome and Metabolomics. Animals, 16(6), 976. https://doi.org/10.3390/ani16060976
Vancouver
Fan J, Xue X, Zhang H, Wang F, Chao Z, Wei L, et al. Intestinal Development in Wuzhishan Pigs at Different Growth Phases: Insights from Microbiome and Metabolomics. Animals. 2026;16(6):976. doi:10.3390/ani16060976
BibTeX
@article{Fan2026,
author = {Fan, Jing and Xue, Xinyu and Zhang, Haojie and Wang, Feng and Chao, Zhe and Wei, Limin and Liu, Hailong and Ren, Yuwei and Sun, Ruiping},
title = {Intestinal Development in Wuzhishan Pigs at Different Growth Phases: Insights from Microbiome and Metabolomics},
journal = {Animals},
year = {2026},
volume = {16},
number = {6},
pages = {976},
doi = {10.3390/ani16060976}
}
EUVIMED